NCI-H1650
品系基本信息
*使用本品系發(fā)表的文獻需注明: NCI-H1650 cell line (Cat. NO. NM-F09) was purchased from Shanghai Model Organisms Center, Inc..
驗證數(shù)據(jù)
I.?Characterization of in vivo?growth kinetics
The NCI-H1650?cells?were subcutaneously inoculated into the M-NSG mice.
Figure?1. Tumor growth curve of NCI-H1650 xenograft model (n=12)
Figure?2. Body weight change of NCI-H1650 xenograft model (n=12)
Figure?3. Survival curve of NCI-H1650 xenograft model (n=12)
野生型細胞株不進行出售服務(wù)，僅作為荷瘤鼠和體內(nèi)藥效進行服務(wù)。
你也可能感興趣
Tamoxifen誘導Cre-ERT2小鼠 使用指南
Cre-ERT2在無Tamoxifen誘導的情況下，在細胞質(zhì)內(nèi)處于無活性狀態(tài)；當Tamoxifen誘導后，Tamoxifen的代謝產(chǎn)物4-OHT（雌激素類似物）與ERT結(jié)合，可使Cre-ERT2進核發(fā)揮Cre重組酶活性。
查看
